Concepts (147)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Travel Medicine | 5 | 2014 | 86 | 0.780 |
Why?
|
Travel | 8 | 2016 | 791 | 0.640 |
Why?
|
Tropical Medicine | 1 | 2014 | 49 | 0.460 |
Why?
|
Communicable Diseases | 2 | 2014 | 892 | 0.320 |
Why?
|
Dengue Virus | 3 | 2016 | 203 | 0.320 |
Why?
|
Physicians, Primary Care | 1 | 2014 | 605 | 0.290 |
Why?
|
Dengue | 3 | 2016 | 256 | 0.290 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2015 | 3966 | 0.260 |
Why?
|
Serologic Tests | 2 | 2013 | 378 | 0.190 |
Why?
|
Referral and Consultation | 1 | 2014 | 3573 | 0.190 |
Why?
|
Hepatitis B | 2 | 2013 | 702 | 0.150 |
Why?
|
Scabies | 1 | 2015 | 14 | 0.130 |
Why?
|
Endemic Diseases | 2 | 2013 | 187 | 0.130 |
Why?
|
Diagnostic Errors | 2 | 2013 | 1270 | 0.130 |
Why?
|
Sexually Transmitted Diseases | 1 | 2020 | 626 | 0.120 |
Why?
|
Dengue Vaccines | 1 | 2013 | 14 | 0.120 |
Why?
|
Medication Adherence | 2 | 2015 | 2099 | 0.110 |
Why?
|
Genes, MHC Class I | 1 | 2010 | 258 | 0.090 |
Why?
|
Comprehension | 1 | 2015 | 617 | 0.090 |
Why?
|
Health Literacy | 1 | 2015 | 425 | 0.090 |
Why?
|
Vaccination | 4 | 2016 | 3354 | 0.080 |
Why?
|
HLA-B Antigens | 1 | 2010 | 352 | 0.080 |
Why?
|
HIV Infections | 4 | 2020 | 16882 | 0.080 |
Why?
|
Minocycline | 1 | 2009 | 163 | 0.080 |
Why?
|
Mass Screening | 2 | 2013 | 5282 | 0.070 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2015 | 1883 | 0.070 |
Why?
|
Antibodies, Viral | 2 | 2016 | 3194 | 0.070 |
Why?
|
Counseling | 1 | 2013 | 1535 | 0.070 |
Why?
|
Immunoglobulin G | 2 | 2016 | 4575 | 0.060 |
Why?
|
Antigen Presentation | 1 | 2010 | 1273 | 0.060 |
Why?
|
Yellow Fever Vaccine | 2 | 2016 | 37 | 0.060 |
Why?
|
Disease Outbreaks | 1 | 2013 | 1785 | 0.060 |
Why?
|
Boston | 5 | 2020 | 9348 | 0.060 |
Why?
|
Self Report | 1 | 2014 | 3618 | 0.060 |
Why?
|
Patient Compliance | 1 | 2013 | 2708 | 0.050 |
Why?
|
Pancreatitis | 1 | 2009 | 1102 | 0.050 |
Why?
|
Skin | 1 | 2015 | 4393 | 0.050 |
Why?
|
Decision Making | 1 | 2015 | 3909 | 0.050 |
Why?
|
Divorce | 1 | 2020 | 79 | 0.050 |
Why?
|
Viral Load | 3 | 2015 | 3325 | 0.050 |
Why?
|
Baltimore | 1 | 2020 | 228 | 0.040 |
Why?
|
Chicago | 1 | 2020 | 241 | 0.040 |
Why?
|
Comorbidity | 1 | 2013 | 10450 | 0.040 |
Why?
|
Malaria, Vivax | 1 | 2001 | 175 | 0.040 |
Why?
|
Kainic Acid | 1 | 1998 | 197 | 0.040 |
Why?
|
New York City | 1 | 2020 | 719 | 0.040 |
Why?
|
Young Adult | 5 | 2016 | 57267 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2016 | 3885 | 0.040 |
Why?
|
Cognition | 1 | 2014 | 6844 | 0.040 |
Why?
|
Yellow Fever | 1 | 2016 | 53 | 0.030 |
Why?
|
Cerebral Ventricles | 1 | 1998 | 542 | 0.030 |
Why?
|
Middle Aged | 9 | 2020 | 216054 | 0.030 |
Why?
|
Asia | 1 | 2016 | 612 | 0.030 |
Why?
|
Male | 12 | 2016 | 354311 | 0.030 |
Why?
|
Adult | 8 | 2016 | 216658 | 0.030 |
Why?
|
Africa | 1 | 2016 | 696 | 0.030 |
Why?
|
Nerve Degeneration | 1 | 1998 | 752 | 0.030 |
Why?
|
Rhode Island | 1 | 2014 | 348 | 0.030 |
Why?
|
Female | 12 | 2020 | 385090 | 0.030 |
Why?
|
Retrospective Studies | 4 | 2016 | 78758 | 0.030 |
Why?
|
Caribbean Region | 1 | 2013 | 195 | 0.030 |
Why?
|
Consultants | 1 | 2013 | 53 | 0.030 |
Why?
|
HIV-1 | 1 | 2010 | 6981 | 0.030 |
Why?
|
Antidiarrheals | 1 | 2012 | 45 | 0.030 |
Why?
|
Receptors, Metabotropic Glutamate | 1 | 1994 | 209 | 0.030 |
Why?
|
Typhoid-Paratyphoid Vaccines | 1 | 2012 | 39 | 0.030 |
Why?
|
Hepatitis B Antibodies | 1 | 2013 | 160 | 0.030 |
Why?
|
Brazil | 1 | 2016 | 1288 | 0.030 |
Why?
|
United States | 3 | 2015 | 70772 | 0.030 |
Why?
|
Hepatitis B Surface Antigens | 1 | 2013 | 307 | 0.020 |
Why?
|
Immunoglobulin M | 1 | 2016 | 1537 | 0.020 |
Why?
|
Friends | 1 | 2012 | 154 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2009 | 7269 | 0.020 |
Why?
|
Humans | 15 | 2020 | 752741 | 0.020 |
Why?
|
Sexual Behavior | 1 | 2020 | 2072 | 0.020 |
Why?
|
HLA-C Antigens | 1 | 2010 | 145 | 0.020 |
Why?
|
HLA-A Antigens | 1 | 2010 | 230 | 0.020 |
Why?
|
HIV Long-Term Survivors | 1 | 2010 | 126 | 0.020 |
Why?
|
India | 1 | 2016 | 2239 | 0.020 |
Why?
|
HIV Antigens | 1 | 2010 | 347 | 0.020 |
Why?
|
Hepatitis B virus | 1 | 2013 | 524 | 0.020 |
Why?
|
CD4 Lymphocyte Count | 1 | 2015 | 2561 | 0.020 |
Why?
|
Skin Diseases, Bacterial | 1 | 2009 | 65 | 0.020 |
Why?
|
Hypothalamus | 1 | 1994 | 1066 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 1994 | 1708 | 0.020 |
Why?
|
Antibiotic Prophylaxis | 1 | 2012 | 647 | 0.020 |
Why?
|
Internationality | 1 | 2013 | 999 | 0.020 |
Why?
|
Prevalence | 2 | 2013 | 15404 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3500 | 0.020 |
Why?
|
Child | 4 | 2016 | 78594 | 0.020 |
Why?
|
Adolescent | 4 | 2016 | 86713 | 0.020 |
Why?
|
Aged | 5 | 2020 | 165629 | 0.020 |
Why?
|
Social Support | 1 | 2014 | 2145 | 0.020 |
Why?
|
Amino Acids | 1 | 2010 | 1744 | 0.010 |
Why?
|
Haplotypes | 1 | 2010 | 2776 | 0.010 |
Why?
|
Protein Conformation | 1 | 2010 | 4010 | 0.010 |
Why?
|
Malaria | 1 | 2012 | 1243 | 0.010 |
Why?
|
Child, Preschool | 2 | 2016 | 41390 | 0.010 |
Why?
|
Massachusetts | 1 | 2014 | 8721 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2013 | 39223 | 0.010 |
Why?
|
Papua New Guinea | 1 | 2001 | 42 | 0.010 |
Why?
|
Pilot Projects | 1 | 2014 | 8413 | 0.010 |
Why?
|
Mefloquine | 1 | 2001 | 55 | 0.010 |
Why?
|
Family | 1 | 2012 | 3175 | 0.010 |
Why?
|
Health Behavior | 1 | 2012 | 2648 | 0.010 |
Why?
|
Models, Molecular | 1 | 2010 | 5460 | 0.010 |
Why?
|
Developing Countries | 1 | 2013 | 2847 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2015 | 13042 | 0.010 |
Why?
|
Blood Gas Analysis | 1 | 2001 | 381 | 0.010 |
Why?
|
Schizophrenia | 1 | 1998 | 6923 | 0.010 |
Why?
|
Alleles | 1 | 2010 | 6954 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2015 | 58361 | 0.010 |
Why?
|
Pulmonary Gas Exchange | 1 | 2001 | 382 | 0.010 |
Why?
|
Immunity, Innate | 1 | 2010 | 3002 | 0.010 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2010 | 4549 | 0.010 |
Why?
|
Positive-Pressure Respiration | 1 | 2001 | 637 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2014 | 20026 | 0.010 |
Why?
|
Limbic System | 1 | 1998 | 423 | 0.010 |
Why?
|
Risk Factors | 2 | 2013 | 73094 | 0.010 |
Why?
|
Logistic Models | 1 | 2010 | 13441 | 0.010 |
Why?
|
Aging | 1 | 1994 | 8752 | 0.010 |
Why?
|
Antimalarials | 1 | 2001 | 905 | 0.010 |
Why?
|
Disease Progression | 1 | 2010 | 13364 | 0.010 |
Why?
|
Embryonic and Fetal Development | 1 | 1994 | 438 | 0.010 |
Why?
|
Intracellular Membranes | 1 | 1994 | 391 | 0.010 |
Why?
|
Blotting, Northern | 1 | 1994 | 1572 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2013 | 25454 | 0.010 |
Why?
|
Risk Assessment | 1 | 2013 | 23554 | 0.010 |
Why?
|
Prospective Studies | 1 | 2016 | 53863 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2010 | 12432 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2010 | 15657 | 0.010 |
Why?
|
Infant | 1 | 2012 | 35447 | 0.010 |
Why?
|
Rats | 2 | 1998 | 24248 | 0.010 |
Why?
|
Tissue Distribution | 1 | 1994 | 2335 | 0.010 |
Why?
|
Critical Care | 1 | 2001 | 2696 | 0.000 |
Why?
|
Cohort Studies | 1 | 2010 | 40939 | 0.000 |
Why?
|
Blotting, Western | 1 | 1994 | 5149 | 0.000 |
Why?
|
Hippocampus | 1 | 1998 | 3713 | 0.000 |
Why?
|
Cognition Disorders | 1 | 1998 | 4042 | 0.000 |
Why?
|
Rats, Sprague-Dawley | 1 | 1994 | 8285 | 0.000 |
Why?
|
Calcium | 1 | 1994 | 5774 | 0.000 |
Why?
|
Immunohistochemistry | 1 | 1994 | 11395 | 0.000 |
Why?
|
RNA, Messenger | 1 | 1994 | 13011 | 0.000 |
Why?
|
Time Factors | 1 | 1998 | 40195 | 0.000 |
Why?
|
Neurons | 1 | 1994 | 9439 | 0.000 |
Why?
|
Animals | 2 | 1998 | 169600 | 0.000 |
Why?
|
Brain | 1 | 1994 | 26598 | 0.000 |
Why?
|
Concepts
(147)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(33)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_